Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionLABU - Direxion Daily S&P Biotech Bull 3X Shares Direxion Daily S&P Biotech Bull 3X Shares
Latest Disclosed Ownership129,949 shares
Latest Disclosed Value $ 3,655,465
LABU - Direxion Daily S&P Biotech Bull 3X Shares Direxion Daily S&P Biotech Bull 3X Shares reports 26.35% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 29, 2026 - LABU - Direxion Daily S&P Biotech Bull 3X Shares Direxion Daily S&P Biotech Bull 3X Shares filed a NPORT-P form disclosing ownership of 129,949 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $3,655,465 USD as of April 30, 2026. The entity filed a previous NPORT-P on April 1, 2026 disclosing 102,851 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 26.35% during the quarter. The current value of the position is $4,092,094 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-29 2026-04-30 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 129,949 27,098 26.35 3,655 46.26 0.7045
2026-04-01 2026-01-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 102,851 -72,010 -41.18 2,499 -32.80 0.4336
2025-12-29 2025-10-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 174,861 67,579 62.99 3,719 62.54 0.4552
2025-09-29 2025-07-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 107,282 12,541 13.24 2,288 -0.56 0.3629
2025-06-27 2025-04-30 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 94,741 -16,414 -14.77 2,301 -8.22 0.3816
2025-04-01 2025-01-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 111,155 -6,458 -5.49 2,508 -2.18 0.2999
2024-12-30 2024-10-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 117,613 -55,717 -32.15 2,564 -14.22 0.2870
2024-09-30 2024-07-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 173,330 -206,984 -54.42 2,988 -47.79 0.2735
2024-06-28 2024-04-30 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 380,314 42,196 12.48 5,724 17.56 0.6031
2024-04-01 2024-01-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 338,118 -62,672 -15.64 4,869 -2.11 0.4713
2024-01-02 2023-10-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 400,790 -291,570 -42.11 4,974 -48.06 0.7334
2023-09-28 2023-07-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 692,360 217,669 45.85 9,575 26.70 0.9136
2023-06-29 2023-04-30 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 474,691 88,848 23.03 7,557 26.46 0.7627
2023-03-31 2023-01-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 385,843 -49,284 -11.33 5,977 -0.98 0.5459
2022-12-27 2022-10-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 435,127 178,674 69.67 6,035 129.82 0.5187
2022-09-29 2022-07-31 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 256,453 3,925 1.55 2,626 36.49 0.2601
2022-06-29 2022-04-30 NP Catalyst Pharmaceuticals Inc. COM STK USD0.001 EC US14888U1016 252,528 -17,168 -6.37 1,924 23.89 0.2865
2022-04-01 2022-01-31 NP Catalyst Pharmaceuticals Inc COM STK USD0.001 EC US14888U1016 269,696 117 0.04 1,553 -2.33 0.1639
2021-12-28 2021-10-31 NP Catalyst Pharmaceuticals Inc COM STK USD0.001 EC US14888U1016 269,579 4,230 1.59 1,591 2.65 0.2023
2021-09-27 2021-07-31 NP Catalyst Pharmaceuticals Inc COM STK USD0.001 EC US14888U1016 265,349 -165,814 -38.46 1,550 -21.53 0.2110
2021-06-28 2021-04-30 NP Catalyst Pharmaceuticals Inc COM STK USD0.001 EC US14888U1016 431,163 368,913 592.63 1,975 773.45 0.2756
2021-03-31 2021-01-31 NP Catalyst Pharmaceuticals Inc COM EC US14888U1016 62,250 -104,476 -62.66 227 -54.34 0.0597
2020-12-28 2020-10-31 NP Catalyst Pharmaceuticals Inc COM EC US14888U1016 166,726 -24,199 -12.67 495 -39.63 0.1694
2020-09-25 2020-07-31 NP Catalyst Pharmaceuticals Inc COM EC US14888U1016 190,925 -28,013 -12.79 821 -20.93 0.1980
2020-06-25 2020-04-30 NP Catalyst Pharmaceuticals Inc COM EC US14888U1016 218,938 -44,330 -16.84 1,038 -4.16 0.2698
2020-03-30 2020-01-31 NP Catalyst Pharmaceuticals Inc COM EC US14888U1016 263,268 125,836 91.56 1,082 66.46 0.2811
2019-12-26 2019-10-31 NP Catalyst Pharmaceuticals Inc COM EC US14888U1016 137,432 137,432 650 0.1334
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.